Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
198 studies found for:    Restless Legs Syndrome
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
Condition: Idiopathic Restless Legs Syndrome
Intervention: Drug: Neupro®
2 Completed
Has Results
Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: ropinirole controlled release (CR)-RLS
3 Terminated Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: rasagiline;   Drug: placebo (sugar pill)
4 Active, not recruiting Cranial Electrotherapy for Military Beneficiaries With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Device: Active CES Device Alpha-Stim®;   Device: Sham Device
5 Terminated Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Condition: Restless Leg Syndrome
Interventions: Drug: Gabapentin immediate release;   Drug: Gabapentin enacarbil extended release
6 Completed
Has Results
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
Condition: Idiopathic Restless Legs Syndrome
Interventions: Drug: placebo and pregabalin;   Drug: pramipexol;   Drug: Pregabalin
7 Completed 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
Conditions: Restless Legs Syndrome (RLS);   Restless Legs Syndrome
Intervention: Drug: ropinirole CR-RLS
8 Completed RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome
Condition: Restless Leg Syndrome
Intervention: Device: RESTIFFIC™ Brand Pressure Application System
9 Completed Altered Brain GABA and Glutamate in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
10 Completed Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
Conditions: Restless Legs Syndrome;   Restless Legs Syndrome (RLS)
Intervention: Drug: ropinirole controlled-release for RLS
11 Active, not recruiting Glutamate, Hyperarousal and Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
12 Completed
Has Results
Botulinum Toxin to Treat Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Botulinum Toxin A
13 Completed
Has Results
Bupropion and Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Bupropion;   Drug: Placebo
14 Unknown  Neuroma Injections to Treat Restless Legs Syndrome - RCT
Condition: Restless Legs Syndrome
Interventions: Drug: equal parts of 0.5% plain Marcaine and 2% lidocaine mixed with 0.8 mg Depo-medrol/4% absolute alcohol in a total injection volume of 1 ml;   Drug: Normal saline - 1ml
15 Recruiting A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome
Condition: Restless Legs Syndrome
Interventions: Device: MMF07 Foot Massager;   Device: Heat Therapy
16 Completed ASP8825 - Study in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: ASP8825;   Drug: Placebo
17 Completed Restless Legs Syndrome Treatment With Botulinum Toxin
Condition: Restless Legs Syndrome
Intervention: Drug: BNT (intradermal injection)
18 Terminated Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: aplindore MR tablets or Placebo
19 Completed
Has Results
Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
20 Completed Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Interventions: Drug: IPX159;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.